BPC-157 is a synthetic peptide widely studied for tissue repair and gut health. It is researched most often for Tendon & ligament healing, Gut lining repair, Muscle recovery and Anti-inflammatory effects. Extensive animal/preclinical research; limited human clinical data. This guide walks through what BPC-157 is, how it's studied, what it's commonly combined with, and — just as important — where the science stops. It's educational information only, not medical advice.
What is BPC-157?
BPC-157 is a synthetic peptide derived from a protein found in gastric juice. It is one of the most widely discussed research peptides for soft-tissue healing, and preclinical studies have explored its role in tendon, ligament, muscle and gastrointestinal repair.
Also known as: Body Protection Compound 157, PL 14736.
How does BPC-157 work?
BPC-157 is a synthetic fragment derived from a protective protein found in gastric juice. In animal research it appears to promote angiogenesis (new blood-vessel formation) and to modulate growth-factor and nitric-oxide pathways involved in healing, which is why so much of the literature focuses on tendon, ligament, muscle and gut-lining repair. It is also studied for its stabilizing effects on the gastrointestinal tract.
What is BPC-157 researched for?
In the research and community discussion, BPC-157 comes up most often in connection with Tendon & ligament healing, Gut lining repair, Muscle recovery and Anti-inflammatory effects. Remember that "researched for" is not the same as "proven to treat" — these are the directions the science has explored, not established outcomes.
- Tendon & ligament healing
- Gut lining repair
- Muscle recovery
- Anti-inflammatory effects
What does the research actually show?
Extensive animal/preclinical research; limited human clinical data. The honest framing matters here: promising mechanisms and early results are genuinely interesting, but they are not the same as proven, approved therapy. Anyone presenting BPC-157 as a guaranteed treatment is getting ahead of the evidence.
What is BPC-157 typically stacked with?
In the literature and community discussion, BPC-157 is most often combined with TB-500 and KPV, based on complementary mechanisms. Selpho never provides dosing or protocols — combinations should only be considered with a licensed professional, since interactions and individual context matter.
Safety and considerations
Most evidence comes from rodent studies. Long-term human safety data is limited. Not approved as a drug in most jurisdictions. Because the responsible framing is educational rather than prescriptive, Selpho provides no dosing, protocols, or purchase links, and always points back to a licensed professional for any decision. If you are dealing with a real health concern, that professional — not a peptide — is where planning should start.
Where to learn more about BPC-157
To go deeper, see the BPC-157 library page for a quick reference; published research on PubMed; Selpho's free AI Peptide Advisor to see where BPC-157 might fit your goals.
Frequently asked questions
Most studies look at soft-tissue and gastrointestinal healing — tendons, ligaments, muscle, and the gut lining — along with anti-inflammatory effects. The bulk of this evidence comes from animal models.
No. BPC-157 is not an approved drug in most jurisdictions and human clinical data is limited. The research is largely preclinical, so its effects and safety in people are not established.
It is frequently discussed alongside TB-500 for recovery, and with KPV for gut and inflammatory support. Selpho does not provide dosing or protocols — always consult a licensed professional.
Not sure if BPC-157 fits your goals?
Describe your situation and Selpho's free AI advisor will suggest research-backed peptides — no signup needed.
Try the Peptide AdvisorThis guide is for educational purposes only and is not medical advice, a diagnosis, or a recommendation to use any compound. It contains no dosing or purchase information. Always consult a licensed healthcare professional before considering any peptide.